Cobenfy 20 mg/1

Xanomeline and trospium chloride, the active ingredient in Cobenfy, is a muscarinic agonist presented as a 20 mg/1 capsule for oral use. It is used to treat schizophrenia in adults. GNH USA supplies Cobenfy as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies, and clinics worldwide.

Cobenfy is a combination medication designed to manage symptoms of schizophrenia, a mental illness characterized by disturbed or unusual thinking, loss of interest in life, and strong or inappropriate emotions. The exact mechanism of how xanomeline and trospium works to treat schizophrenia is not fully understood, but it is classified as a muscarinic agonist.

Cobenfy is indicated for the treatment of schizophrenia in adults. Schizophrenia is a mental illness that affects thinking, emotions, and behavior. The following are the primary uses of Cobenfy:

- Schizophrenia: Helps manage symptoms such as disturbed or unusual thinking, loss of interest in life, and strong or inappropriate emotions.

Cobenfy can cause various side effects, ranging from mild to serious. Common side effects include:

Common Side Effects: - Dry mouth - Constipation - Nausea - Dizziness - Blurry vision - Excessive sleepiness - Abdominal pain - Diarrhea

Serious or Rare Side Effects: - High blood pressure - Urinary retention - Slow-moving gut - Orthostatic hypotension (sudden drop in blood pressure upon standing) - Extrapyramidal symptoms (movement disorders), which may include drooling, involuntary muscle movements, and muscle spasms - Central nervous system symptoms, such as confusion, excessive sleepiness, and hallucinations

Before taking Cobenfy, it is important to consider several precautions to ensure safe and effective use. Inform your healthcare provider if you have any of the following conditions or are taking any other medications. Always follow the prescribed dosage and do not stop taking the medication without consulting your doctor. Store at room temperature: keep in the original pack, protect from moisture.

Cobenfy can interact with other medications, which may affect its efficacy or increase the risk of side effects. It is crucial to inform your healthcare provider about all the medications you are taking. Major interactions to avoid include:

Major Interactions (Avoid): - Anticholinergic drugs: May enhance the anticholinergic effects of Cobenfy - Drugs that prolong the QT interval: May increase the risk of cardiac side effects - Other antipsychotic medications: May increase the risk of extrapyramidal symptoms

Moderate Interactions (Monitor Closely): - Antihypertensive drugs: May enhance the hypotensive effects of Cobenfy - Drugs metabolized by CYP2D6: May affect the metabolism of Cobenfy - Drugs that cause sedation: May enhance the sedative effects of Cobenfy